Form4insider filings, from the source

Insider holders · CIK 0001567514

Intra-Cellular Therapies, Inc. · ITCI

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
ALAFI CAPITAL CO LLC10% Owner3,953,270—3,953,270Oct 3, 2017 · 6:08 pm EDTForm 4
Moshe Alafi10% Owner—3,953,2703,953,270Oct 3, 2017 · 6:11 pm EDTForm 4
Christopher D AlafiDirector748,916503,7531,252,669Jan 3, 2019 · 8:05 pm ESTForm 4
Joel S MarcusDirector21,6711,143,7311,165,402Nov 13, 2018 · 5:34 pm ESTForm 4
Sharon MatesChairman, President & CEO1,138,707—1,138,707Jan 8, 2019 · 9:28 pm ESTForm 4
Morton I. Sosland10% Owner—732,548732,548Mar 12, 2015 · 1:04 pm EDTForm 4
Allen A. FienbergVP of Business Development295,000197,823492,823Sep 11, 2015 · 4:53 pm EDTForm 4
Rory B RiggsDirector40,057226,670266,727Jan 3, 2019 · 8:15 pm ESTForm 4
Lawrence P. WennogleVice President, Drug Discovery126,500—126,500Jun 9, 2015 · 5:04 pm EDTForm 4
Richard A LernerDirector11,43066,91178,341Jan 3, 2019 · 8:11 pm ESTForm 4
Robert E DavisSVP, Chief Scientific Officer43,989—43,989Jan 8, 2019 · 9:16 pm ESTForm 4
Kimberly E. VanoverSVP, Early Stage Clinical Dev.27,068—27,068Jan 8, 2019 · 9:19 pm ESTForm 4
Lawrence J. HinelineSVP of Finance CFO25,232—25,232Mar 1, 2019 · 7:41 pm ESTForm 4
Robert L Van NostrandDirector4,955—4,955Jan 3, 2019 · 8:19 pm ESTForm 4
Michael HalsteadEVP and General Counsel191—191Jan 8, 2019 · 9:24 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.